At present, bariatric surgery (BS) is considered the benchmark treatment of morbid obesity, with well-established indications providing effective long-term outcomes [2, 3] that lead to sustained weight loss [4] and improvement in most weight-related comorbidities [5,6,7], with relatively low morbidity and mortality [8,9,10]
1 Con el creciente inters en el control de peso y la salud metablica, los suplementos de GLP-1 han surgido como una herramienta prometedora para abordar problemas como la obesidad, la diabetes e incluso la salud cardiovascular
10.1016/S1359-6446(04)03316-1 148 SamsonS
Because it acts on a different pathway than GLP-1 drugs, the National Institute of Diabetes and Digestive and Kidney Diseases describes how prescription medications treat overweight and obesity by changing appetite signaling rather than relying on willpower
The best peptide stack for weight loss examines these combination approaches
or liraglutide, in Saxenda